Table 2.
Genotype frequencies (percentages) in symptomatic and asymptomatic participants included in the present study
| Marker/status | Symptomatic participants | Asymptomatic participants | Total | P* |
|---|---|---|---|---|
| rs733175 |
||||
| TT |
30 (51.7) |
50 (57.5) |
80 (55.2) |
0.029 |
| CT |
24 (41.4) |
33 (37.9) |
57 (39.3) |
|
| CC |
4 (6.9) |
4 (4.6) |
8 (5.5) |
|
| rs6449213 |
||||
| TT |
30 (51.7) |
57 (65.5) |
87 (60.0) |
0.006 |
| CT |
25 (43.1) |
24 (27.6) |
49 (33.8) |
|
| CC |
3 (5.2) |
6 (6.9) |
9 (6.2) |
|
| rs1014290 |
||||
| TT |
27 (46.6) |
47 (54.0) |
74 (51.0) |
0.020 |
| CT |
25 (43.1) |
31 (35.6) |
56 (38.6) |
|
| CC |
6 (10.3) |
9 (10.3) |
15 (10.3) |
|
| rs737267 |
||||
| GG |
28 (48.3) |
51 (58.6) |
79 (54.5) |
0.011 |
| GT |
26 (44.8) |
28 (32.2) |
54 (37.2) |
|
| TT | 4 (6.9) | 8 (9.2) | 12 (8.3) |
*Fisher exact test.